PreciseDx’s “Analytical Validation of a Digital Breast Cancer Test Predicting Recurrence in Early-Stage Breast Cancer” Featured in Clinical Breast Cancer
AP News,
PreciseBreast™ assessment demonstrates ability to predict the recurrence of early-stage breast cancer within 6 years NEW YORK…